cytarabine has been researched along with Adverse Drug Event in 29 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (34.48) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (27.59) | 29.6817 |
2010's | 8 (27.59) | 24.3611 |
2020's | 3 (10.34) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Cai, H; Han, S; He, J; Li, S; Lin, X; Liu, Y; Shi, Y; Wang, X; Xiu, M | 1 |
Gollol Raju, NS; Jayananda, S; Khalid, H; Muzaffar, M | 1 |
Choudhary, D; Doval, D; Khandelwal, V; Kumar Sharma, S; Kumar, M | 1 |
DiNardo, CD; Gandhi, VV; O'Brien, S; Ravandi, F | 1 |
Kang, HR; Kang, MG; Kim, JY; Lim, KH; Park, HK | 1 |
Brandwein, JM; Gupta, V; Howson-Jan, K; Leber, BF; MacAlpine, K; Minden, MD; Moore, M; Schimmer, AD; Schuh, AC; Wright, J; Yee, KW | 1 |
Bentz, M; Dreyling, M; Hiddemann, W; Jentsch-Ullrich, K; Mueck, R; Rohrberg, R; von Schilling, C; Weidmann, E; Weigert, O | 1 |
Brice, P; Briere, J; Faure, P; Franchi, P; Gisselbrecht, C; Lignon, J; Madelaine, I; Mounier, N; Sibon, D; Thieblemont, C | 1 |
Denich, D; Gärtner, F; Ohmle, B; Parmar, S; Pitterle, K; Seeringer, A; Stingl, JC; Syrovets, T | 1 |
Andretta, C; Camera, A; Ciancia, R; Della Cioppa, P; Picardi, M; Rinaldi, CR; Rossi, M; Rotoli, B; Selleri, C; Villa, MR; Volpicelli, M | 1 |
Brown, CA; Hashem, B; Lane, JE; Lesher, JL; Marzec, T | 1 |
Aygun, N; Sherman, PM | 1 |
Ravet, O | 1 |
Arai, Y; Doki, N; Ishida, F; Kano, Y; Kawai, Y; Komatsu, N; Miyawaki, S; Morii, T; Ogura, M; Ohno, R; Takeshita, A; Usui, N | 1 |
Marmer, DJ; Steele, RW | 1 |
Ferrell, J; Gray, LE; Kavlock, RJ; Ostby, J | 1 |
Gierlichs, HW; Heintz, R; Planz, G; Rahn, KH; Stephany, W | 1 |
Honegger, P; Werffeli, P | 1 |
Ariatti, M; Jones, PA | 1 |
Oizumi, K; Oka, S | 1 |
Berry, DH | 1 |
Simone, J | 1 |
Friedman, IA; Gynn, TN; Messmore, HL | 1 |
Crosby, WH | 1 |
3 review(s) available for cytarabine and Adverse Drug Event
Article | Year |
---|---|
[Toxic effects of medications on the cornea].
Topics: Belgium; Chloroquine; Cornea; Corneal Diseases; Cytarabine; Drug-Related Side Effects and Adverse Reactions; Humans; Isotretinoin; Keratitis; Pharmaceutical Preparations; Rifabutin; Tamoxifen | 2007 |
[Chemotherapy].
Topics: Anti-Bacterial Agents; Asparaginase; Bleomycin; Cephalosporins; Cytarabine; Daunorubicin; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Humans; Kanamycin; Penicillins; Rifampin; Vincristine | 1972 |
Drug-induced thrombocytopenia.
Topics: Aged; Agglutination Tests; Alkaloids; Alkylating Agents; Anti-Bacterial Agents; Anticonvulsants; Antigen-Antibody Reactions; Azathioprine; Blood Cell Count; Blood Platelet Disorders; Blood Platelets; Bone Marrow; Bone Marrow Examination; Clot Retraction; Complement Fixation Tests; Cytarabine; Drug-Related Side Effects and Adverse Reactions; Fluorouracil; Humans; Hypoglycemic Agents; Infant, Newborn; Kidney Function Tests; Liver Function Tests; Male; Mercaptopurine; Middle Aged; Prothrombin Time; Thrombocytopenia; Tranquilizing Agents; Vinblastine; Vincristine | 1972 |
4 trial(s) available for cytarabine and Adverse Drug Event
Article | Year |
---|---|
A phase I study of tipifarnib combined with conventional induction and consolidation therapy for previously untreated patients with acute myeloid leukemia aged 60 years and over.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug-Related Side Effects and Adverse Reactions; Gastrointestinal Diseases; Humans; Leukemia, Myeloid, Acute; Maximum Tolerated Dose; Middle Aged; Quinolones; Remission Induction | 2009 |
A novel regimen combining high dose cytarabine and bortezomib has activity in multiply relapsed and refractory mantle cell lymphoma - long-term results of a multicenter observation study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Cytarabine; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Lymphoma, Mantle-Cell; Male; Middle Aged; Pyrazines; Salvage Therapy; Survival Analysis | 2009 |
Phase I trial of FLAGM with high doses of cytosine arabinoside for relapsed, refractory acute myeloid leukemia: study of the Japan Adult Leukemia Study Group (JALSG).
Topics: Adult; Cytarabine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Granulocyte Colony-Stimulating Factor; Humans; Japan; Leukemia, Myeloid, Acute; Middle Aged; Mitoxantrone; Recurrence; Vidarabine | 2007 |
Acute lymphocytic leukemia in childhood.
Topics: Asparaginase; Black People; Bone Marrow Examination; Central Nervous System Diseases; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Immunosuppression Therapy; Infections; Injections, Spinal; Leukemia, Lymphoid; Leukopenia; Male; Methotrexate; Prednisone; Remission, Spontaneous; Vincristine | 1974 |
22 other study(ies) available for cytarabine and Adverse Drug Event
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Exposure to cytarabine causes side effects on adult development and physiology and induces intestinal damage via apoptosis in Drosophila.
Topics: Animals; Apoptosis; Cytarabine; Drosophila; Drosophila melanogaster; Drug-Related Side Effects and Adverse Reactions; Leukemia, Myeloid, Acute | 2023 |
Successful Rechallenge With Cytarabine After Isolated Hyperbilirubinemia: A Rarely Reported Adverse Effect.
Topics: Cytarabine; Drug-Related Side Effects and Adverse Reactions; Humans; Hyperbilirubinemia; Iatrogenic Disease | 2020 |
Cytarabine ears - A side effect of cytarabine therapy.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug-Related Side Effects and Adverse Reactions; Ear; Female; Hematologic Neoplasms; Humans; Leukemia, Myeloid, Acute; Middle Aged | 2020 |
Elacytarabine (CP-4055) in the treatment of acute myeloid leukemia.
Topics: Cytarabine; Drug Approval; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Humans; Leukemia, Myeloid, Acute; Randomized Controlled Trials as Topic; Treatment Outcome | 2013 |
Two cases of cytarabine syndrome successfully resolved by desensitization.
Topics: Aged; Antimetabolites, Antineoplastic; Chills; Cytarabine; Desensitization, Immunologic; Drug-Related Side Effects and Adverse Reactions; Female; Fever; Humans; Hypotension; Leukemia, Myeloid, Acute; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Shivering; Syndrome | 2015 |
Rituximab, dexamethasone, cytarabine, and oxaliplatin (R-DHAX) is an effective and safe salvage regimen in relapsed/refractory B-cell non-Hodgkin lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Cytarabine; Dexamethasone; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Recurrence; Retrospective Studies; Rituximab; Salvage Therapy; Treatment Outcome; Young Adult | 2010 |
Variability in transport and biotransformation of cytarabine is associated with its toxicity in peripheral blood mononuclear cells.
Topics: Adult; Antimetabolites, Antineoplastic; Cell Survival; Cells, Cultured; Cytarabine; Cytidine Deaminase; Drug-Related Side Effects and Adverse Reactions; Equilibrative Nucleoside Transporter 1; Exons; Female; Genotype; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Risk Factors; Thioinosine; Young Adult | 2011 |
Intestinal toxicity during induction chemotherapy with cytarabine-based regimens in adult acute myeloid leukemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evaluation; Drug-Related Side Effects and Adverse Reactions; Enterocolitis, Necrotizing; Female; Humans; Infusions, Parenteral; Injections, Subcutaneous; Intestinal Diseases; Leukemia, Myeloid; Male; Middle Aged; Neutropenia; Remission Induction; Retrospective Studies; Thrombocytopenia | 2003 |
Pressure-induced bullae and sweat gland necrosis following chemotherapy induction.
Topics: Acute Disease; Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Blister; Cytarabine; Drug Eruptions; Drug-Related Side Effects and Adverse Reactions; Humans; Idarubicin; Leukemia, Myeloid; Male; Necrosis; Remission Induction; Sweat Gland Diseases; Sweat Glands | 2004 |
Development of a cavum septi pellucidi after Ommaya reservoir placement: report of an unusual complication.
Topics: Adult; Antimetabolites, Antineoplastic; Brain Neoplasms; Burkitt Lymphoma; Catheters, Indwelling; Cerebrospinal Fluid; Cerebrospinal Fluid Pressure; Cytarabine; Drug-Related Side Effects and Adverse Reactions; Epilepsy, Tonic-Clonic; Humans; Infusion Pumps, Implantable; Injections, Intraventricular; Lateral Ventricles; Magnetic Resonance Imaging; Male; Postoperative Complications; Reoperation; Septum Pellucidum; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
Comparison of flow cytometric analysis and [3H]thymidine incorporation for measurement of the effects of drug toxicity on lymphocyte stimulation.
Topics: Bromodeoxyuridine; Cytarabine; DNA; Drug-Related Side Effects and Adverse Reactions; Flow Cytometry; Humans; In Vitro Techniques; Lymphocyte Activation; Lymphocytes; Phytohemagglutinins; Thymidine | 1983 |
Assessment of the utility of postnatal testing following prenatal exposure to forty chemicals.
Topics: Abnormalities, Drug-Induced; Aging; Animals; Body Weight; Cricetinae; Cytarabine; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Evaluation Studies as Topic; Female; Gestational Age; Herbicides; Male; Mice; Mortality; Motor Activity; Phenyl Ethers; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Inbred Strains; Reproduction; Teratogens | 1983 |
[Number and kinds of drug side-effects in a medical clinic (author's transl)].
Topics: Adrenal Cortex Hormones; Adult; Aged; Cytarabine; Drug-Related Side Effects and Adverse Reactions; Female; Glucocorticoids; Heparin; Hodgkin Disease; Humans; Kidney Failure, Chronic; Leukemia; Male; Middle Aged; Renal Dialysis | 1976 |
Use of aggregating cell cultures for toxicological studies.
Topics: Animals; beta-Alanine; Biotransformation; Brain; Cell Aggregation; Cell Division; Cells, Cultured; Cholera Toxin; Cytarabine; Drug-Related Side Effects and Adverse Reactions; Myelin Sheath; Rats; Rats, Inbred Strains; Thymidine | 1988 |
N4-chloroacetylcytosine arabinoside--a possible pro-drug of cytosine arabinoside.
Topics: Animals; Cell Line; Cell Survival; Cricetinae; Cytarabine; Deoxycytidine; Drug-Related Side Effects and Adverse Reactions; Fibrosarcoma; Prodrugs; Sarcoma, Experimental | 1987 |
The child with acute leukemia.
Topics: Age Factors; Asparaginase; Chickenpox; Child, Preschool; Counseling; Cyclophosphamide; Cytarabine; Cytomegalovirus Infections; Daunorubicin; Drug-Related Side Effects and Adverse Reactions; Humans; Injections, Spinal; Leukemia; Mercaptopurine; Methotrexate; Patient Care Planning; Pediatrics; Physician-Patient Relations; Prednisone; Prognosis; Sex Factors; Vincristine | 1974 |
Treatment of AGL.
Topics: Aminopterin; Cortisone; Cytarabine; Daunorubicin; Drug Tolerance; Drug-Related Side Effects and Adverse Reactions; Hemorrhage; Humans; Infections; Leukemia, Myeloid, Acute; Patient Isolators; Steroids; Transfusion Reaction | 1969 |